I-Mab Appoints Two New Directors to Board
Ticker: NBP · Form: 6-K · Filed: Aug 25, 2025 · CIK: 1778016
Sentiment: neutral
Topics: governance, board-of-directors
TL;DR
I-Mab adds two new directors to its board.
AI Summary
On August 22, 2025, I-Mab appointed Dr. Robert Lenz and Ms. Xin Li to its Board of Directors. This filing is a Form 6-K, reporting a significant change in the company's directorate.
Why It Matters
Changes in board composition can signal shifts in company strategy, governance, or future direction, potentially impacting investor confidence and stock performance.
Risk Assessment
Risk Level: low — This filing reports routine corporate governance changes, specifically board appointments, with no immediate financial or operational implications disclosed.
Key Players & Entities
- I-Mab (company) — Registrant
- Dr. Robert Lenz (person) — Newly appointed director
- Ms. Xin Li (person) — Newly appointed director
- August 22, 2025 (date) — Date of board appointments
FAQ
Who were the individuals appointed to I-Mab's Board of Directors?
Dr. Robert Lenz and Ms. Xin Li were appointed to I-Mab's Board of Directors.
When were these appointments made?
The appointments were made on August 22, 2025.
What type of filing is this for I-Mab?
This is a Form 6-K filing.
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, typically used to report material information not required to be filed on a Form 20-F.
What is the principal executive office address for I-Mab?
The principal executive offices of I-Mab are located at 2440 Research Boulevard, Suite 400, Rockville, MD 20850.
Filing Stats: 795 words · 3 min read · ~3 pages · Grade level 9.4 · Accepted 2025-08-25 07:09:48
Filing Documents
- pr_-_new_bod_members_-_8.htm (6-K) — 34KB
- imab-ex99_1.htm (EX-99.1) — 25KB
- img44095488_0.jpg (GRAPHIC) — 40KB
- 0001778016-25-000011.txt ( ) — 114KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. I-MAB By : /s/ Joseph Skelton Name : Joseph Skelton Title : Chief Financial Officer Date: August 25, 2025